Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status:
Completed
Trial end date:
2020-04-16
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the safety, tolerability, and therapeutic
equivalence of GDC 268 to Clindamycin Phosphate Topical Lotion, 1% and to compare the
efficacy of these two products to the GDC vehicle lotion (i.e., placebo) in the treatment of
acne vulgaris.